Logo-npj

Original

Protective effects of bexagliflozin on renal function in a rat model of ischemia-reperfusion injury; an experimental animal study
Ghada A. Alkhafaji ORCID, Ali M. Janabi* ORCID
J Nephropharmacol. 2025;14(2): e12760. doi: 10.34172/npj.2025.12760
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy CrossRef 0
Mini-Review

Immune checkpoint inhibitors and IgA nephropathy; A rare side effect
Maryam Dehghani Mobarakeh ORCID, Ahmadreza Maghsoudi* ORCID
J Nephropharmacol. 2025;14(2): e12762. doi: 10.34172/npj.2025.12762
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy CrossRef 0
Review

Thrombotic microangiopathy in IgA nephropathy; new evidence and ideas
Paniz Pourpashang ORCID, Hamid Nasri* ORCID
J Nephropharmacol. 2025;14(2): e12764. doi: 10.34172/npj.2025.12764
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy CrossRef 0
Review

Earthquake-related acute kidney shut down; an overview of pre-existing associated factors
Mehdi Yarahmadi ORCID, Mohammad Reza Moonesan* ORCID
J Nephropharmacol. 2025;14(2): e12777. doi: 10.34172/npj.2025.12777
Article logoArticle
PDFPDF
XMLXML
Cited By:
Review

Air pollution and kidney disease; a comprehensive updated overview of recent evidence on functional and structural alterations
Iman Ghasemzadeh ORCID, Mohadeseh Javadi ORCID, Pourya Bagherian Kenari ORCID, Ali Emadzadeh ORCID, Meysam Ziaei Mehr ORCID, Elham Ahmadipour ORCID, Hossein Mardanparvar ORCID, Seyedeh Arefeh Javadi* ORCID
J Nephropharmacol. 2025;14(2): e12789. doi: 10.34172/npj.2025.12789
Article logoArticle
PDFPDF
XMLXML
Cited By:
Clinical Trial

Comparison the clinical efficacy of intravenous fentanyl and ketorolac in relieving renal colic pain; a controlled randomized clinical trial
Davood Arab ORCID, Arash Ardestanizadeh ORCID, Reihane Ghanipour, Majid Mirmohammadkhani ORCID, Mohammadreza Moonesan* ORCID
J Nephropharmacol. 2025;14(2): e12774. doi: 10.34172/npj.2025.12774
Article logoArticle
PDFPDF
XMLXML
Cited By:
Mini-Review

Application of the updated international IgA nephropathy prediction tool in pediatric patients
Paniz Pourpashang* ORCID
J Nephropharmacol. 2025;14(2): e12800. doi: 10.34172/npj.2025.12800
Article logoArticle
PDFPDF
XMLXML
Cited By:
Meta Analysis

The association between triglyceride-glucose index and contrast-induced nephropathy; a systematic review and meta-analysis
Maede Safari ORCID, Akram Kadhim Kareem ORCID, Khorsid Rigi ORCID, Akbar Abbasi ORCID, Bahman Mokhtarinia ORCID, Paniz Pourpashang ORCID, Elham Ahmadipour ORCID, Batool Heydarisadegh ORCID, Halime Aali* ORCID
J Nephropharmacol. 2025;14(2): e12771. doi: 10.34172/npj.2025.12771
Article logoArticle
PDFPDF
XMLXML
Cited By:
Original

Complications of remdesivir in COVID-19 patients with kidney disease: a retrospective cohort study
Neda Najafi ORCID, Houshang Sanadgol* ORCID, Hounaz Akbari ORCID, Asal Sadat Karimi, Negin Sanadgol, Atra Ajdari, Mohsen Vahedi
J Nephropharmacol. 2025;14(2): e12745. doi: 10.34172/npj.2025.12745
Article logoArticle
PDFPDF
XMLXML
Cited By:
Meta Analysis

Relationship between left ventricular end-diastolic pressure and contrast-induced nephropathy; a systematic review and meta-analysis
Mayyadah Hameed Rashid* ORCID, Abbas Muhammed Khalil ORCID, Ali Thoulfikar A. Imeer ORCID, Mohammed Abdul-Mounther Othman ORCID, Omer Mansib Kassid ORCID, Abdul Amir H. Kadhum ORCID, Hayfaa A. Mubarak ORCID, Qais R. Lahhob ORCID
J Nephropharmacol. 2025;14(2): 12750. doi: 10.34172/npj.2025.12750
Article logoArticle
PDFPDF
XMLXML
Cited By: